Tissue biopsy

PNAClamp™ Mutation Detection Kit IDH2

Ref. PNAC-5101

IDH2 is frequently mutated in glioma, acute myeloid leukemia, and myelodysplastic syndromes. Mutations generally involve point mutations at the R140 and R172 residues of the protein.

Tests per card —
Packaging 25 tests
Contact us for product availability and technical details.

About the Product

IDH2 is frequently mutated in glioma, acute myeloid leukemia, and myelodysplastic syndromes. Mutations generally involve point mutations at the R140 and R172 residues of the protein. Mutations in IDH1 and IDH2 result in deleterious “gain of function”: instead of converting isocitrate to α-ketoglutarate, mutated IDH1 or IDH2 converts isocitrate to 2-hydroxyglutarate. 2-hydroxyglutarate inhibits other proteins involved in epigenetic regulation.

Total 11 IDH2 mutations can be detected.

Technical Characteristics

Mutations - Codon 140 7
Mutations - Codon 172 4
Total mutations 11
Detection limit 1% LOD with 10 ng wild/mutant type mixed DNA
Running time within 3 hours
Procedure sample preparationExtraction of Total DNAAmplification of target DNA by Real-Time PCRAnalysis of Result

Key Features

  • High sensitivity and specificity even with small amount of DNA (1% LOD with 10 ng wild/mutant type mixed DNA)
  • Real-Time PCR based ready-to-use kit
  • Short running time (within 3 hours)

Technical Information

No technical information available for this product.

Compatibility

Compatible sample type:

  • FFPE tissue
  • Biopsy tissue

Compatible Real-Time PCR machine:

  • CFX96 (Bio-Rad)
  • LightCycler 480II (Roche)
  • ABI7500 (Thermo Fisher Scientific)
  • ABI7900HT (Thermo Fisher Scientific)
  • StepOnePlus (Thermo Fisher Scientific)
  • QuantStudio 5 (Thermo Fisher Scientific)
  • Rotor-Gene Q (Qiagen)

Packaging

25 tests